Perhaps a little bit of an increase when the OLE results come out. Definitely when we have successfully past Clock Stop One. Starts April 25th and ends when Anavex has successfully answered all questions.
Aside from that happening, I don't see starting more trials helping the share price.
Potentially a rock solid readout of "A Study of ANAVEX3-71 in Adults With Schizophrenia (SZ-001)" could help, but I currently see that trial being where the P2a AD or P2 PDD trials where back when and not as far ahead as the Rett EXELLENCE trial was supposed to be.